Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Morten Stilund
Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients With Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel
PLoS ONE
Multidisciplinary
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients With Multiple Sclerosis
PLoS ONE
Multidisciplinary
Related publications
Evaluating Biomarkers of Neuronal Degeneration and Neuroinflammation in CSF of Patients With Multiple Sclerosis–osteopontin as a Potential Marker of Clinical Severity
Journal of the Neurological Sciences
Neurology
Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple Sclerosis
Frontiers in Immunology
Allergy
Immunology
Diffusion Tensor-Mri Evidence for Extra-Axonal Neuronal Degeneration in Caudate and Thalamic Nuclei of Patients With Multiple Sclerosis
American Journal of Neuroradiology
Medicine
Nuclear Medicine
Neurology
Imaging
Radiology
Role of Interlekin-35 as a Biomarker in Patients With Newly Diagnosed Hashimoto’s Thyroiditis
Endocrine Regulations
Endocrinology
Metabolism
Diabetes
CSF Β-Amyloid Predicts Prognosis in Patients With Multiple Sclerosis
Multiple Sclerosis
Neurology
Serum Metallothionein in Newly Diagnosed Patients With Childhood Solid Tumours.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Circulating miR-150 in CSF Is a Novel Candidate Biomarker for Multiple Sclerosis
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Serum Levels of OPG, RANKL and RANKL/OPG Ratios in Newly-Diagnosed Patients With Multiple Myeloma. Clinical Correlations
Haematologica
Hematology
